Benefit of nicorandil using an immunologic murine model of experimental colitis

Central European Journal of Biology

Volumn 4, Issue 1, 2009, Pages 74-85

  Hosseini Tabatabaei, Azadeh ^a   Esmaily, Hadi ^a   Rahimian, Reza ^b   Khorasani, Reza ^a   Baeeri, Maryam ^a   Barazesh Morgani, Ahmadreza ^a   Sari Aslani, Fatemeh ^c   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

2,4,6 trinitrobenzene sulphonic acid (TNBS); Immunologic; Inflammatory bowel disease; Inflammatory cytokines; Myeloperoxidase; Nicorandil

Indexed keywords

ANGINA; ANIMALIA; MURINAE; RATTUS;

EID: 59349108132     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-008-0047-0     Document Type: Article

References (66)

1. A.R. Jurjus N.N. Khoury J.M. Reimund 2004 Animal models of inflammatory bowel disease J. Pharmacol. Toxicol. Method. 50 81 92
2. A. Rezaie R.D. Parker M. Abdollahi 2007 Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 52 2015 2021
3. O. Blokhina E. Virolainen K.V. Fagerstedt 2003 Anti-oxidants, oxidative damage and oxygen deprivation stress: a review Ann. Bot. (Lond). 91 179 194
4. S.J. Middleton M. Shorthouse J.O. Hunter 1993 Increased nitric oxide synthesis in ulcerative colitis Lancet 341 465 466
5. R. Panaccione J.G. Ferraz P. Beck 2005 Advances in medical therapy of inflammatory bowel disease Curr. Opin. Pharmacol. 5 566 572
6. L. Langmead D.S. Rampton 2006 Review article: complementary and alternative therapies for inflammatory bowel disease Review, Aliment. Pharmacol. Ther. 23 341 349
7. L. Ashtaral-Nakhai A. Mohammadirad N. Yasa B. Minaie S. Nikfar G. Ghazanfari 2007 Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease Evid. Based Complement. Alternat. Med. 4 43 50
8. H. Ghafari N. Yasa A. Mohammadirad G. Dehghan M.J. Zamani S. Nikfar 2006 Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity Hum. Exp. Toxicol. 25 325 332
9. G. Ghazanfari B. Minaie N. Yasa L. Nakhai A. Mohammadirad S. Nikfar 2006 Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases Toxicol. Mech. Methods 16 365 372
10. Rahimi R., Mozaffari S., Abdollahi M., On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies, Dig. Dis. Sci., 2008, [Epub ahead of print] (DOI 10.1007/s10620-008-0368-x)
11. F. Ebrahimi H. Esmaily M. Baeeri A. Mohammadirad S. Fallah M. Abdollahi 2008 Molecular evidences on the benefits of N-acetylcysteine in experimental colitis Cent. Eur. J. Biol. 3 135 142
12. B. Elahi S. Nikfar S. Derakhshani M. Vafaie M. Abdollahi 2007 On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials Dig. Dis. Sci. 53 1278 1284
13. A. Rezaie B. Taghavi Bayat M. Abdollahi 2005 Biologic management of fistulizing Crohn's disease Int. J. Pharmacol. 1 17 24
14. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2008 A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission Arch. Med. Sci. 4 185 190
15. R. Rahimi S. Nikfar F. Rahimi B. Elahi S. Derakhshani M. Vafaie 2008 A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease Dig. Dis. Sci. 53 2524 2531
16. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2007 A meta-analysis of antibiotic therapy for active ulcerative colitis Dig. Dis. Sci. 52 2920 2925
17. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2006 A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn's disease Clin. Ther. 28 1983 1988
18. M.C. Dubinsky 2004 Targeting Therapy in Pediatric Inflammatory Bowel Disease Curr. Treat. Options Gastroenterol. 7 391 405
19. K. Akai Y. Wang K. Sato N. Sekiguchi A. Sugimura T. Kumagai 1995 Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels J. Cardiovasc. Pharmacol. 26 541 547
20. A. Hosseini-Tabatabaei M. Abdollahi 2008 Potassium channel openers and improvement of toxic stress: Do they have role in the management of Inflammatory bowel disease? Inflamm. Allergy Drug Targets 7 129 135
21. G.J. Heywood P.S. Thomas 2002 Nicorandil inhibits degranulation and TNF-alpha release from RBL-2H3 cells Inflamm. Res. 51 176 181
22. H.T. Facundo J.G. De Paula A.J. Kowaltowski 2007 Mitochondrial ATP-sensitive K+ channels are redox-sensitive pathways that control reactive oxygen species production Free Radic. Biol. Med. 42 1039 1048
23. H.T. Facundo J.G. De Paula A.J. Kowaltowski 2005 Mitochondrial ATP-sensitive K+ channels prevent oxidative stress, permeability transition and cell death J. Bioenerg. Biomembr. 37 75 82
24. Y.P. Wang H. Maeta K. Mizoguchi T. Suzuki Y. Yamashita M. Oe 2002 Intestinal ischemia preconditions myocardium: role of protein kinase C and mitochondrial K(ATP) channel Cardiovasc. Res. 55 576 582
25. Y. Teshima M. Akao W.A. Baumgartner E. Marbán 2003 Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels Brain. Res. 990 45 50
26. M. Akao Y. Teshima E. Marbán 2002 Antiapoptotic effect of nicorandil mediated by mitochondrial atpsensitive potassium channels in cultured cardiac myocytes J. Am. Coll. Cardiol. 40 803 810
27. K. Nagata K. Obata M. Odashima A. Yamada F. Somura T. Nishizawa 2003 Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect J. Mol. Cell. Cardiol. 35 1505 1512
28. J. Xu K. Nagata K. Obata S. Ichihara H. Izawa A. Noda 2005 Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats Hypertension 46 719 724
29. H.A. Ismail M.M. Khalifa M.K. Hassan O.M. Ashour 2007 Insights in the mechanisms underlying the anti-ulcer activity of nicorandil Pharmazie 62 60 67
30. M. Mourelle J. Vilaseca F. Guarner A. Salas J.R. Malagelada 1996 Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase Am. J. Physiol. 270 G425 G430
31. M. Abdollahi A.R. Dehpour G. Baharnouri 1998 Alteration by rubidium of rat submandibular secretion of protein and N-acetyl-D-glucosaminidase Tox. Subst. Mech. 17 121 131
32. J.L. Wallace C.M. Keenan D. Gale T.S. Shoupe 1992 Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis Gastroenterology 102 18 27
33. A. Mustafa A. El-Medany H.H. Hagar G. El-Medany 2006 Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis Pharmacol. Res. 53 324 330
34. S. Cuzzocrea A. Ianaro N.S. Wayman E. Mazzon B. Pisano L. Dugo 2003 The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat Br. J. Pharmacol. 138 678 688
35. G. Dehghan A. Shafiee M.H. Ghahremani S.K. Ardestani M. Abdollahi 2007 Antioxidant potential of various extracts from Ferula szovitsiana in relation to their phenolic content Pharm. Biol. 45 691 699
36. F. Astaneie M. Afshari A. Mojtahedi S. Mostafalou M.J. Zamani B. Larijani 2005 Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients Arch. Med. Res. 36 376 381
37. O.H. Lowry N.J. Rosebrough A.L. Farr R.J. Randall 1951 Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 265 275
38. M.I. Torres M. García-Martin M.I. Fernández N. Nieto A. Gil A. Ríos 1999 Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study Dig. Dis. Sci. 44 2523 2529
39. M. Kolgazi N. Jahovic M. Yuksel F. Ercan I. Alican 2007 α-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats J. Gastroenterol. Hepatol. 22 1859 1865
40. C. Shen G. De Hertogh D.M. Bullens G. Van Assche K. Geboes P. Rutgeerts 2007 Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm. Bowel. Dis. 13 308 316
41. R. Rahimi S. Nikfar M. Abdollahi 2007 Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials Biomed. Pharmacother. 61 75 80
42. R. Rahimi S. Nikfar M. Abdollahi 2007 Meta-analysis technique confirms the effectiveness of anti-TNF-a in the management of active ulcerative colitis when administered in combination with corticosteroids Med. Sci. Monitor. 13 PI13 PI18
43. O. Ludwiczek E. Vannier I. Borggraefe A. Kaser B. Siegmund C.A. Dinarello 2004 Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease Clin. Exp. Immunol. 138 323 329
44. N.J. Simmonds D.S. Rampton 1993 Inflammatory bowel disease-a radical view Gut 34 865 868
45. M. Suzuki T. Saito T. Sato M. Tamagawa T. Miki S. Seino H. Nakaya 2003 Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice Circulation 107 682 685
46. P.J. Hanley J. Daut 2005 K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms J. Mol. Cell. Cardiol. 39 17 50
47. I. Inoue H. Nagase K. Kishi T. Higuti 1991 ATP-sensitive K+ channel in the mitochondrial inner membrane Nature 352 244 247
48. G. Deby-Dupont C. Deby M. Lamy 1999 Neutrophil myeloperoxidase revisited: its role in health and disease Intensivmed. 36 500 551
49. L. Kruidenier I. Kuiper W. Van Duijn M.A. Mieremet-Ooms R.A. van Hogezand C.B. Lamers 2003 Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease J. Pathol. 201 17 27
50. L. Kruidenier I. Kuiper C.B. Lamers H.W. Verspaget 2003 Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants J. Pathol. 201 28 36
51. A.O. Ahmed M. Sharifzadeh S. Nikfar H.R. Jamshidi M. Abdollahi 2006 Prevention by L-arginine/nitric oxide of chlordiazepoxide-induced toxic reactions in the rat salivary gland Toxicol. Mech. Method. 16 331 337
52. M. Abdollahi A.R. Dehpour F. Shafayee 2000 L-Arginine/nitric oxide pathway and interaction with lead acetate on rat submandibulary gland function Pharmacol. Toxicol. 87 198 203
53. G. Kolios V. Valatas S.G. Ward 2004 Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle Immunology 113 427 437
54. M.D. Barrachina J. Panes J.V. Esplugues 2001 Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development Curr. Pharm. Des. 7 31 48
55. G. Jahanshahi V. Motavasel A. Rezaie A.A. Hashtroudi N.E. Daryani M. Abdollahi 2004 Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases Dig. Dis. Sci. 49 1752 1757
56. S. Horinaka N. Kobayashi A. Yabe H. Asakawa H. Yagi Y. Mori 2004 Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction Cardiovasc. Drugs Ther. 18 13 22
57. S. Horinaka N. Kobayashi T. Higashi K. Hara S. Hara H. Matsuoka 2001 Nicorandil enhances cardiac endothelial nitric oxide synthase expression via activation of adenosine triphosphate-sensitive K channel in rat J. Cardiovasc. Pharmacol. 38 200 210
58. K. Pompermayer D.G. Souza G.G. Lara K.D. Silveira G.D. Cassali A.A. Andrade 2005 The ATPsensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats Kidney Int. 67 1785 1796
59. K. Pompermayer F.A. Amaral C.T. Fagundes A.T. Vieira F.Q. Cunha M.M. Teixeira 2007 Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury Eur. J. Pharmacol. 556 215 222
60. A.G. Flavio F.Q. Cunha H.D. Francescato T.J. Soares R.S. Costa F. Barbosa Junior 2007 ATP-sensitive potassium channel blockage attenuates cisplatin-induced renal damage Kidney Blood Press. Res. 30 289 298
61. P. Sarkhail S. Rahmanipour S. Fadyevatan A. Mohammadirad G. Dehghan G. Amin 2007 Antidiabetic effect of Phlomis anisodonta: Effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes Pharmacol. Res. 56 261 266
62. T.M. Cocks S.J. King J.A. Angus 1990 Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro Br. J. Pharmacol. 100 375 378
63. D.S. Rampton C.E. Collins 1993 Review article: thromboxanes in inflammatory bowel disease-pathogenic and therapeutic implications Aliment. Pharmacol. Ther. 7 357 367
64. S. Reichert A. Antunes P. Tréchot A. Barbaud M. Weber J.L. Schmutz 1997 Major aphthous stomatitis induced by nicorandil Eur. J. Dermatol. 7 132 133
65. A. Watson O. Al-Ozairi A. Fraser M. Loudon T. O'Kelly 2002 Nicorandil associated anal ulceration Lancet 360 546 547
66. D.J. McKenna J. Donnelly D.K. Armstrong 2007 Nicorandil-induced leg ulceration Br. J. Dermatol. 156 394 396